Thus, it is thought that, in FGFR-driven cancer for instance, fast FGFR feedback activation following initial suppression of the SHP2 inhibitor pathway promotes the open conformation of SHP2 and results in resistance to SHP2 inhibitors (200). This evidence concerns the gene PTPN11 and cancer.